189 related articles for article (PubMed ID: 35993622)
1. Retraction Note: The carcinogenic complex lncRNA FOXP4-AS1/EZH2/LSD1 accelerates proliferation, migration and invasion of gastric cancer.
Chen RY; Ju Q; Feng LM; Yuan Q; Zhang L
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(15):5311. PubMed ID: 35993622
[TBL] [Abstract][Full Text] [Related]
2. LncRNA DCST1-AS1 regulated cell proliferation, migration, invasion and apoptosis in gastric cancer by targeting miR-605-3p.
Su YZ; Cui MF; Du J; Song B
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):6827. PubMed ID: 34859842
[TBL] [Abstract][Full Text] [Related]
3. LncRNA ZEB2-AS1 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma cell through miR-574-3p/HMGA2 axis.
Xu JH; Chen RZ; Liu LY; Li XM; Wu CP; Zhou YT; Yan JD; Zhang ZY
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3397. PubMed ID: 34002806
[TBL] [Abstract][Full Text] [Related]
4. Retraction Note: METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.
Meng QZ; Cong CH; Li XJ; Zhu F; Zhao X; Chen FW
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):4947. PubMed ID: 35916787
[TBL] [Abstract][Full Text] [Related]
5. LncRNA ASB16-AS1 promotes proliferation and inhibits apoptosis of non small cell lung cancer cells by activating the Wnt/β catenin signaling pathway.
Tan LJ; Liu JT; Yang M; Ju T; Zhang YS
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1766. PubMed ID: 33660829
[TBL] [Abstract][Full Text] [Related]
6. LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in prostate cancer via targeting miR-647.
Qian C; Liao CH; Tan BF; Chen YF; Dang BW; Chen JL; Liu CB
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8628. PubMed ID: 32964947
[TBL] [Abstract][Full Text] [Related]
7. Retraction Note: MicroRNA-375 accelerates the invasion and migration of colorectal cancer through targeting RECK.
Wei LJ; Bai DM; Wang ZY; Liu BC
Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1229. PubMed ID: 36876660
[TBL] [Abstract][Full Text] [Related]
8. LncRNA INHBA-AS1 promotes cell growth, migration, and invasion of oral squamous cell carcinoma by sponging miR-143-3p.
Ma WQ; Chen J; Fang W; Yang XQ; Zhu A; Zhang D; Zhong HL; Yang B; Luo Z
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9240. PubMed ID: 33015761
[TBL] [Abstract][Full Text] [Related]
9. Retraction Note: LncRNA BRE-AS1 acts as a tumor suppressor factor in bladder cancer via mediating STAT3.
Zhang L; Liu B; Deng QH; Li JX
Eur Rev Med Pharmacol Sci; 2023 May; 27(10):4326. PubMed ID: 37259712
[TBL] [Abstract][Full Text] [Related]
10. LncRNA DLEU1 accelerates the malignant progression of clear cell renal cell carcinoma via regulating miRNA-194-5p.
He GZ; Yu SY; Zhou QP; Chen ML; Zhang YW; Zheng Y; Zhang ZB; Han ZY; Yu J
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):10920. PubMed ID: 33215404
[TBL] [Abstract][Full Text] [Related]
11. Retraction Note: Combination therapy with metformin and IL-12 to inhibit the growth of hepatic carcinoma by promoting apoptosis and autophagy in HepG2-bearing mice.
Jin Z; Jia BX; Tan LD; Chen QM; Liu YH
Eur Rev Med Pharmacol Sci; 2022 Oct; 26(19):6892. PubMed ID: 36263565
[TBL] [Abstract][Full Text] [Related]
12. Retraction Note: LncRNA RUSC1-AS1 promotes the proliferation of breast cancer cells by epigenetic silence of KLF2 and CDKN1A.
Hu CC; Liang YW; Hu JL; Liu LF; Liang JW; Wang R
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6404. PubMed ID: 36196690
[TBL] [Abstract][Full Text] [Related]
13. Retraction Note: Salinomycin enhances radiotherapy sensitivity and reduces expressions of BIRC5 and NEIL2 in nasopharyngeal carcinoma.
Chang Y; Geng Q; Bao Q; Hu P
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6012. PubMed ID: 36111899
[TBL] [Abstract][Full Text] [Related]
14. Retraction Note: Effect of atorvastatin on pulmonary arterial hypertension in rats through PI3K/AKT signaling pathway.
Wang YY; Cheng XD; Jiang H
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):7881. PubMed ID: 37750615
[TBL] [Abstract][Full Text] [Related]
15. Retraction Note: MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1.
Chen JY; Xu LF; Hu HL; Wen YQ; Chen D; Liu WH
Eur Rev Med Pharmacol Sci; 2024 May; 28(10):3476. PubMed ID: 38856147
[TBL] [Abstract][Full Text] [Related]
16. LncRNA LUCAT1 promotes rowth, migration, and invasion of oral squamous cell carcinoma by upregulating PCNA.
Kong Y; Feng Y; Xiao YY; Liu SC; Li XG; Yang QL; Chu WH; Liu JG
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7569. PubMed ID: 32744674
[TBL] [Abstract][Full Text] [Related]
17. Retraction Note.
Listed NA
Eur Rev Med Pharmacol Sci; 2024 Feb; 28(3):861. PubMed ID: 38375730
[TBL] [Abstract][Full Text] [Related]
18. Retraction Note: Long non-coding RNA DLEU7-AS1 promotes the occurrence and development of colorectal cancer via Wnt/β-catenin pathway.
Liu XB; Han C; Sun CZ
Eur Rev Med Pharmacol Sci; 2024 Apr; 28(7):2630. PubMed ID: 38639498
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-28-5p regulates glioma cell proliferation, invasion and migration by targeting SphK1.
Chen HS; Lu AQ; Yang PY; Liang J; Wei Y; Shang YW; Li Q
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10302. PubMed ID: 33155264
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA DSCAM-AS1 indicates a poor prognosis and modulates cell proliferation, migration and invasion in ovarian cancer via upregulating SOX4.
Li Y; Hao J; Jiang YM; Liu Y; Zhang SH
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):10915. PubMed ID: 33215399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
